Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple mechanisms of dimethyl fumarate in amyloid β‐induced neurotoxicity in human neuronal cells
Michela Campolo, Giovanna Casili, Marika Lanza, et al.
Journal of Cellular and Molecular Medicine (2017) Vol. 22, Iss. 2, pp. 1081-1094
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

NRF2 as a Therapeutic Target in Neurodegenerative Diseases
Mikah S. Brandes, Nora E. Gray
ASN NEURO (2020) Vol. 12, pp. 175909141989978-175909141989978
Open Access | Times Cited: 216
Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity
Wen Gao, Lin Guo, Yan Yang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 137
Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer's disease
Darius J.R. Lane, Billie Metselaar, Mark Greenough, et al.
Essays in Biochemistry (2021) Vol. 65, Iss. 7, pp. 925-940
Closed Access | Times Cited: 116
Dimethyl fumarate, a two‐edged drug: Current status and future directions
Nathaniel Edward Bennett Saidu, Niloufar Kavian, Karen Leroy, et al.
Medicinal Research Reviews (2019) Vol. 39, Iss. 5, pp. 1923-1952
Closed Access | Times Cited: 131
Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer’s and Parkinson’s Disease: Insight into the Role of Nrf-2 and A2AR Signaling
Muhammad Ikram, Tae Ju Park, Tahir Ali, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 902-902
Open Access | Times Cited: 113
Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease
Francisca Villavicencio Tejo, Rodrigo A. Quintanilla
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1069-1069
Open Access | Times Cited: 98
Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases
Sarah Adriana Scuderi, Alessio Ardizzone, Irene Paterniti, et al.
Antioxidants (2020) Vol. 9, Iss. 7, pp. 630-630
Open Access | Times Cited: 88
NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Ángel Cores, Marta Piquero, Mercedes Villacampa, et al.
Biomolecules (2020) Vol. 10, Iss. 6, pp. 904-904
Open Access | Times Cited: 73
Normal and Pathological NRF2 Signalling in the Central Nervous System
Tony Heurtaux, David Bouvier, Alexandre Bénani, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1426-1426
Open Access | Times Cited: 45
Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases
Irena Majkutewicz
European Journal of Pharmacology (2022) Vol. 926, pp. 175025-175025
Closed Access | Times Cited: 42
A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease
Yi Sun, Lijuan Xu, Dongpeng Zheng, et al.
Redox Biology (2023) Vol. 64, pp. 102793-102793
Open Access | Times Cited: 24
Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications
Clara Mayer, Lluís Riera‐Ponsati, Sakari Kauppinen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
Molecular Mechanisms of Neuroprotection: The Interplay of Klotho, SIRT-1, Nrf2, and HO-1 in Neurological Health
R.S. Rana, R Mukherjee, Sidharth Mehan, et al.
Behavioural Brain Research (2025), pp. 115545-115545
Closed Access | Times Cited: 1
Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models
Fiona Kerr, Ivana Bjedov, Oyinkan Sofola-Adesakin
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 71
Modulation of Keap1/Nrf2/ARE Signaling Pathway by Curcuma- and Garlic-Derived Hybrids
Melania Maria Serafini, Michele Catanzaro, Francesca Fagiani, et al.
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 64
Protein Hydrolysates from Anchovy (Engraulis encrasicolus) Waste: In Vitro and In Vivo Biological Activities
Alessia Giannetto, Emanuela Esposito, Marika Lanza, et al.
Marine Drugs (2020) Vol. 18, Iss. 2, pp. 86-86
Open Access | Times Cited: 55
Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease
Yi Sun, Jiaxuan Huang, Yufei Chen, et al.
Bioorganic Chemistry (2020) Vol. 103, pp. 104172-104172
Open Access | Times Cited: 51
ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation
Jiawei Zhang, Lan Liu, Yaxuan Zhang, et al.
Redox Biology (2022) Vol. 58, pp. 102554-102554
Open Access | Times Cited: 38
Iron dyshomeostasis and ferroptosis in Alzheimer’s disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD
Yuan Zhang, Man Wang, Wenguang Chang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Striking a NRF2: The Rusty and Rancid Vulnerabilities Toward Ferroptosis in Alzheimer's Disease
Darius J.R. Lane, Francesca M. Alves, Scott Ayton, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 1-3, pp. 141-161
Closed Access | Times Cited: 20
Protective Effects of Sulforaphane on Cognitive Impairments and AD-like Lesions in Diabetic Mice are Associated with the Upregulation of Nrf2 Transcription Activity
Die Pu, Yuxing Zhao, Jinliang Chen, et al.
Neuroscience (2018) Vol. 381, pp. 35-45
Closed Access | Times Cited: 57
Supraphysiologic-dose anabolic–androgenic steroid use: A risk factor for dementia?
Marc J. Kaufman, Gen Kanayama, James I. Hudson, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 100, pp. 180-207
Open Access | Times Cited: 48
Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment
Maria Rosito, Claudia Testi, Giacomo Parisi, et al.
Antioxidants (2020) Vol. 9, Iss. 8, pp. 700-700
Open Access | Times Cited: 45
Trilobatin Protects Against Aβ25–35-Induced Hippocampal HT22 Cells Apoptosis Through Mediating ROS/p38/Caspase 3-Dependent Pathway
Nana Chen, Jiao Wang, Yuqi He, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 40
Dimethyl fumarate abridged tauo-/amyloidopathy in a D-Galactose/ovariectomy-induced Alzheimer's-like disease: Modulation of AMPK/SIRT-1, AKT/CREB/BDNF, AKT/GSK-3β, adiponectin/Adipo1R, and NF-κB/IL-1β/ROS trajectories
Israa M Abd El-Fatah, Heba M. A. Abdelrazek, Sherehan M. Ibrahim, et al.
Neurochemistry International (2021) Vol. 148, pp. 105082-105082
Closed Access | Times Cited: 37
Page 1 - Next Page

Scroll to top